Silvercrest Asset Management’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-14,566
Closed -$161K 868
2022
Q1
$161K Sell
14,566
-17,664
-55% -$198K ﹤0.01% 817
2021
Q4
$566K Buy
32,230
+1,753
+6% +$34K ﹤0.01% 655
2021
Q3
$617K Buy
30,477
+6,718
+28% +$173K ﹤0.01% 643
2021
Q2
$785K Sell
23,759
-442
-2% -$16.7K 0.01% 606
2021
Q1
$946K Buy
24,201
+16,258
+205% +$763K 0.01% 572
2020
Q4
$347K Buy
+7,943
New +$271K ﹤0.01% 695

Other funds holding ONEM

Silvercrest Asset Management's ONEM Position: Q2 2022 in Review

Silvercrest Asset Management sold out of 1Life Healthcare (ONEM) in Q2 2022, closing a stake of 14,566 shares — an estimated $161K sold.

Silvercrest Asset Management first reported a position in ONEM in Q4 2020 and held it in 6 quarters. The position peaked at $946K in Q1 2021. 187 funds tracked by Wall St. Rank hold ONEM as of Q2 2022.

  • Silvercrest Asset Management reported no remaining 1Life Healthcare position as of Q2 2022 after selling out during the quarter.
  • Silvercrest Asset Management sold 14,566 1Life Healthcare shares in Q2 2022, an estimated $161K.
  • Silvercrest Asset Management first reported a position in 1Life Healthcare in Q4 2020 and held it in 6 quarters.
  • Silvercrest Asset Management's 1Life Healthcare position peaked at $946K in Q1 2021.
  • 187 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2022.

Based on Silvercrest Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.